The effect of NG-monomethyl- l-arginine on bladder function
Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold,...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 1996-09, Vol.311 (1), p.73-78 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 78 |
---|---|
container_issue | 1 |
container_start_page | 73 |
container_title | European journal of pharmacology |
container_volume | 311 |
creator | Theobald, Robert J. |
description | Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition.
l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis. |
doi_str_mv | 10.1016/0014-2999(96)00404-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78461329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299996004049</els_id><sourcerecordid>78461329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</originalsourceid><addsrcrecordid>eNp9kE1LJDEQhoO46PjxDxT6ILJ7yFr56E4HQVjEdRdEL3oO6XRFI92JJjOC_95uZpijp6Ko530pHkJOGPxmwJoLACYp11r_1M0vAAmS6h2yYK3SFBTju2SxRfbJQSmvAFBrXu-RvbZtJRd6QS4fX7BC79Etq-Sr-1s6pphGXL58DrQaqM3PIYaIVYpVN9i-x1z5VXTLkOIR-eHtUPB4Mw_J09-bx-t_9O7h9v_1nzvquBCa1lZyLhVHIcELrkEBCiWUlL7xzDqmZF_rTmnbupZ3XIpOe143DegeOtuJQ3K-7n3L6X2FZWnGUBwOg42YVsWoVjZsKp5AuQZdTqVk9OYth9HmT8PAzM7MLMTMQoyel8mZmWOnm_5VN2K_DW0kTfezzd0WZwefbXShbDHBJ-W8mbCrNYaTi4-A2RQXMDrsQ570mj6F7__4AiqEhO0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78461329</pqid></control><display><type>article</type><title>The effect of NG-monomethyl- l-arginine on bladder function</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Theobald, Robert J.</creator><creatorcontrib>Theobald, Robert J.</creatorcontrib><description>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition.
l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(96)00404-9</identifier><identifier>PMID: 8884239</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Arginine - pharmacology ; Biological and medical sciences ; Cats ; Enzyme Inhibitors - pharmacology ; Female ; Fundamental and applied biological sciences. Psychology ; Hypogastric Plexus - physiology ; Inhibition ; Male ; Micturition volume threshold ; Muscle Contraction - drug effects ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; Nitric oxide (NO) ; Nitric Oxide Synthase - antagonists & inhibitors ; omega-N-Methylarginine - pharmacology ; Purinergic ; Purinergic Antagonists ; Sympathetic Nervous System - drug effects ; Urinary Bladder - drug effects ; Urinary Bladder - innervation ; Urination - drug effects ; Urodynamics - drug effects ; Vertebrates: urinary system</subject><ispartof>European journal of pharmacology, 1996-09, Vol.311 (1), p.73-78</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</citedby><cites>FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0014-2999(96)00404-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3218726$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8884239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Theobald, Robert J.</creatorcontrib><title>The effect of NG-monomethyl- l-arginine on bladder function</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition.
l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</description><subject>Animals</subject><subject>Arginine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cats</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hypogastric Plexus - physiology</subject><subject>Inhibition</subject><subject>Male</subject><subject>Micturition volume threshold</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>Nitric oxide (NO)</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>omega-N-Methylarginine - pharmacology</subject><subject>Purinergic</subject><subject>Purinergic Antagonists</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Urinary Bladder - drug effects</subject><subject>Urinary Bladder - innervation</subject><subject>Urination - drug effects</subject><subject>Urodynamics - drug effects</subject><subject>Vertebrates: urinary system</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LJDEQhoO46PjxDxT6ILJ7yFr56E4HQVjEdRdEL3oO6XRFI92JJjOC_95uZpijp6Ko530pHkJOGPxmwJoLACYp11r_1M0vAAmS6h2yYK3SFBTju2SxRfbJQSmvAFBrXu-RvbZtJRd6QS4fX7BC79Etq-Sr-1s6pphGXL58DrQaqM3PIYaIVYpVN9i-x1z5VXTLkOIR-eHtUPB4Mw_J09-bx-t_9O7h9v_1nzvquBCa1lZyLhVHIcELrkEBCiWUlL7xzDqmZF_rTmnbupZ3XIpOe143DegeOtuJQ3K-7n3L6X2FZWnGUBwOg42YVsWoVjZsKp5AuQZdTqVk9OYth9HmT8PAzM7MLMTMQoyel8mZmWOnm_5VN2K_DW0kTfezzd0WZwefbXShbDHBJ-W8mbCrNYaTi4-A2RQXMDrsQ570mj6F7__4AiqEhO0</recordid><startdate>19960905</startdate><enddate>19960905</enddate><creator>Theobald, Robert J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960905</creationdate><title>The effect of NG-monomethyl- l-arginine on bladder function</title><author>Theobald, Robert J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2339-5a422472e340f329070e373744f6f1ac174d59b79a8c82b243b9f256609d0bab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Arginine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cats</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hypogastric Plexus - physiology</topic><topic>Inhibition</topic><topic>Male</topic><topic>Micturition volume threshold</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>Nitric oxide (NO)</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>omega-N-Methylarginine - pharmacology</topic><topic>Purinergic</topic><topic>Purinergic Antagonists</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Urinary Bladder - drug effects</topic><topic>Urinary Bladder - innervation</topic><topic>Urination - drug effects</topic><topic>Urodynamics - drug effects</topic><topic>Vertebrates: urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Theobald, Robert J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Theobald, Robert J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of NG-monomethyl- l-arginine on bladder function</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1996-09-05</date><risdate>1996</risdate><volume>311</volume><issue>1</issue><spage>73</spage><epage>78</epage><pages>73-78</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Recent studies have demonstrated the presence of nitric oxide synthase (NO synthase) in lower urinary tract tissues, however, its role in the detrusor is unclear. The current study was designed to determine if NO synthase inhibition alters detrusor activities, including micturition volume threshold, and inhibition of pelvic nerve-evoked contractions by various stimuli. In naive, anesthetized adult cats, inhibition of pelvic nerve-evoked bladder contractions, induced by hypogastric nerve stimulation or the intraarterial administration of NA, ATP, adenosine, β,γ-methylene ATP and 2-methylthio ATP, was measured before and after inhibition of NO synthase. The micturition volume threshold was also measured before and after NO synthase inhibition.
l-NMMA decreased the micturition volume threshold by 38% (2 mg intravesical administration) or 80% (4 mg/kg i.a.). The magnitude of the micturition contractions was modestly increased. These results, and information in the literature, indicate that NO may play a role in the collection phase of the bladder cycle and any alteration of nitric oxide availability could induce or allow development of various bladder malfunctions, such as small bladder diseases, like interstitial cystitis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>8884239</pmid><doi>10.1016/0014-2999(96)00404-9</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 1996-09, Vol.311 (1), p.73-78 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_78461329 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Arginine - pharmacology Biological and medical sciences Cats Enzyme Inhibitors - pharmacology Female Fundamental and applied biological sciences. Psychology Hypogastric Plexus - physiology Inhibition Male Micturition volume threshold Muscle Contraction - drug effects Muscle, Smooth - drug effects Muscle, Smooth - innervation Nitric oxide (NO) Nitric Oxide Synthase - antagonists & inhibitors omega-N-Methylarginine - pharmacology Purinergic Purinergic Antagonists Sympathetic Nervous System - drug effects Urinary Bladder - drug effects Urinary Bladder - innervation Urination - drug effects Urodynamics - drug effects Vertebrates: urinary system |
title | The effect of NG-monomethyl- l-arginine on bladder function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20NG-monomethyl-%20l-arginine%20on%20bladder%20function&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Theobald,%20Robert%20J.&rft.date=1996-09-05&rft.volume=311&rft.issue=1&rft.spage=73&rft.epage=78&rft.pages=73-78&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/0014-2999(96)00404-9&rft_dat=%3Cproquest_cross%3E78461329%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78461329&rft_id=info:pmid/8884239&rft_els_id=0014299996004049&rfr_iscdi=true |